Johnson & Johnson Adds Adolescents to Covid Vaccine Tests
Source: New York Times
Johnson & Johnson on Friday became the third company to enter the race to expand the use of its coronavirus vaccine to adolescents. Researchers have begun testing the drug maker’s vaccine in adolescents 12 to 17 years old, the company announced.
Johnson & Johnson has been lagging its competitors. Pfizer and BioNTech announced on Wednesday that their coronavirus vaccine is extremely effective in young adolescents, perhaps even more so than in adults. Results from a similar trial of Moderna’s vaccine are expected in the next few weeks.
Pfizer, BioNTech and Moderna are also testing their vaccines in children younger than 12. Johnson & Johnson has said it would wait for results from trials in older children before following suit.
A single-shot version of Johnson & Johnson’s vaccine was authorized in February by the Food and Drug Administration for use in adults, and is now being tested on adolescent subjects. Made by Janssen Pharmaceuticals, a subsidiary, the vaccine is authorized in Canada and many other countries. But a mix-up in ingredients at a Baltimore factory may delay future shipments of doses in the United States while the Food and Drug Administration investigates what occurred.
Read more: https://www.msn.com/en-us/health/medical/johnson-and-johnson-adds-adolescents-to-covid-vaccine-tests/ar-BB1ffdhR?li=BBnb7Kz
= new reply since forum marked as read
especially my 13-year-old granddaughter.
Or they found some really small kids?!?!
